Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
about
Diseases associated with defective responses to DNA damageTransfusion-induced bone marrow transplant rejection due to minor histocompatibility antigensCTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model.Clinical Comparison of Non-Myeloablative Conditioning with Anti-Thymocyte Globulin and Fludarabine for Patients with Hematologic Malignancies.Hematopoietic cell transplantation for sickle cell disease: state of the art.EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning.The rise of cell therapy trials for stroke: review of published and registered studies.Poor prognosis osteosarcoma: new therapeutic approach.Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice.Fundamental Principles of Stem Cell Banking.Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation.CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair.Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy.Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients.Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients.
P2860
Q26997852-6289FD3A-913F-4137-A2E3-5A55AA2E1F7AQ34824419-45AF2FBE-EB42-4772-9556-4F12F036DBA5Q34824540-EEF41A1E-08E9-47FC-AAC7-BBCB3C62CC52Q34976550-322A7700-F21F-4B75-848F-54ACD9AE46D5Q35934770-8A900225-EE66-4770-B716-AF0C9A31BEF6Q36717337-A3FB6F1C-F622-4779-8FBA-F1705A1BB8BAQ36746437-8B7EF608-325A-404B-8C33-C13D00E31B84Q37025630-8DE9AE1E-08DB-4A21-BEB6-DEB60595A12DQ37188469-4FB2D399-C2E5-4067-A6EC-B37A829F6253Q37328417-297F9E85-AF39-46E4-8CB6-428D6AF4CB54Q38796131-3CF5A59D-D018-4978-8ACB-6FD11B650A43Q39256130-F5AA2B2E-005C-4FEF-AAC0-015124D6E2BFQ40012751-A4CD6A25-584F-4FA7-9D4A-30C29160C12AQ41627517-3B0732AF-250B-4356-B159-F38187298C53Q43955506-40D1759B-D856-4B35-8C24-A129A90881B2Q44208467-FE50FE5C-423A-49AB-B579-3A6CD63F670BQ46265702-6401D2F1-2D49-472D-AA2E-480FEB934313
P2860
Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@ast
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@en
type
label
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@ast
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@en
prefLabel
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@ast
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@en
P2093
P1476
Nonmyeloablative stem cell tra ...... nt and non-malignant diseases.
@en
P2093
P304
P356
10.1016/J.TRIM.2005.03.009
P577
2005-04-26T00:00:00Z